Overview

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

Status:
Completed

Trial end date:
2013-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the ability of people with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) to use an experimental autoinjector to self inject etanercept (Enbrel®).

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Etanercept